| Dr Katherine Harer, MD | |
|
115 Lincoln St, Framingham, MA 01702 | |
| (508) 383-1000 | |
| (508) 383-1654 |
| Full Name | Dr Katherine Harer |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 115 Lincoln St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063869386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | LP03658 (Rhode Island) | Primary |
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
Meanwhile, news outlets report on a range of other implementation issues, including the decision of Ohio Gov. John Kasich to follow through on forming a state-based exchange despite his opposition to the overhaul, changes to FSAs and the measure's impact on farmers.
Quincy Bioscience, a research-based biotechnology company, is attending the annual Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) sharing promising interim data from the Madison Memory Study, a randomized controlled trial, which shows the jellyfish protein apoaequorin improves cognitive function in individuals with memory concerns.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
Eli Lilly and Company and Boehringer Ingelheim announced today that Cymbalta/Xeristar (duloxetine hydrochloride)(+) has been granted marketing authorization by the European Commission for the treatment of major depressive episodes.
› Verified 6 days ago
| Entity Name | Pratt Pediatric Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590511 PECOS PAC ID: 3779475371 Enrollment ID: O20040329000127 |
News Archive
Meanwhile, news outlets report on a range of other implementation issues, including the decision of Ohio Gov. John Kasich to follow through on forming a state-based exchange despite his opposition to the overhaul, changes to FSAs and the measure's impact on farmers.
Quincy Bioscience, a research-based biotechnology company, is attending the annual Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) sharing promising interim data from the Madison Memory Study, a randomized controlled trial, which shows the jellyfish protein apoaequorin improves cognitive function in individuals with memory concerns.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
Eli Lilly and Company and Boehringer Ingelheim announced today that Cymbalta/Xeristar (duloxetine hydrochloride)(+) has been granted marketing authorization by the European Commission for the treatment of major depressive episodes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine Harer, MD 115 Lincoln St, Framingham, MA 01702-6358 Ph: (508) 383-1000 | Dr Katherine Harer, MD 115 Lincoln St, Framingham, MA 01702 Ph: (508) 383-1000 |
News Archive
Meanwhile, news outlets report on a range of other implementation issues, including the decision of Ohio Gov. John Kasich to follow through on forming a state-based exchange despite his opposition to the overhaul, changes to FSAs and the measure's impact on farmers.
Quincy Bioscience, a research-based biotechnology company, is attending the annual Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) sharing promising interim data from the Madison Memory Study, a randomized controlled trial, which shows the jellyfish protein apoaequorin improves cognitive function in individuals with memory concerns.
BioDelivery Sciences International, Inc. today announced the approval of a New Drug Submission (NDS) by Health Canada, the regulatory authority in Canada, for ONSOLIS (fentanyl buccal soluble film) in the management of breakthrough pain in opioid-tolerant adult patients with cancer. ONSOLIS is the first product approved in Canada for this indication.
Eli Lilly and Company and Boehringer Ingelheim announced today that Cymbalta/Xeristar (duloxetine hydrochloride)(+) has been granted marketing authorization by the European Commission for the treatment of major depressive episodes.
› Verified 6 days ago
Dr. Stacey Dawn Maslow, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 761 Worcester Rd, Framingham, MA 01701 Phone: 508-872-1260 | |
Dr. Gertrude M Moffat, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 Edgell Rd, Framingham, MA 01701 Phone: 508-620-6615 Fax: 508-879-1597 | |
Dr. Charles G Murphy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Dept Of Emergency Medicine, Framingham, MA 01702 Phone: 508-383-1104 | |
Courtney Mcguire, Pediatrics Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1559 | |
Jennifer Eve Novick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8 Lyman Way, Framingham, MA 01701 Phone: 508-877-4141 | |
Dr. Jerry Wortzman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1130 |